(Q39680831)

English

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu

scientific article published on May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

multicenter clinical trial

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

Ronald van Vollenhoven

5

object named as

Ronald F van Vollenhoven

0 references

author name string

Anders A Bengtsson

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gunnar Sturfelt

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Christian Lood

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lars Rönnblom

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Bengt Axelsson

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Birgitta Sparre

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Helén Tuvesson

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Marie Wallén Ohman

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Tomas Leanderson

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1579-1588

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Systemic lupus erythematosus-messages from experimental models

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Decreased levels of pathogenic IgG anti-DNA antibodies in autoimmune mice after linomide treatment

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Systemic lupus erythematosus and the type I interferon system

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

The type I interferon system in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Microarray analysis of interferon-regulated genes in SLE.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.33493

21 January 2018

Identifiers

10.1002/ART.33493

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39680831&oldid=1543943899"